Niagen Bioscience (NAGE) Interest Expenses (2010 - 2026)
Niagen Bioscience's (NAGE) quarterly Interest Expenses came in at $421000.0 in Q1 2026, down 89.55% year-on-year from $4.0 million in Q1 2025, and up 166.19% on a QoQ basis from -$636000.0 in Q4 2025.
Niagen Bioscience (NAGE) Interest Expenses (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of Interest Expenses data on file, last reported at $421000.0 in Q1 2026.
- On a quarterly basis, Interest Expenses fell 89.55% year-over-year to $421000.0 in Q1 2026; TTM through Mar 2026 was $421000.0, a 89.55% decrease from a year earlier, with the FY2025 full-year figure at $40.5 million, down 8.58% from the prior year.
- Interest Expenses for Q1 2026 stood at $421000.0, up from -$636000.0 in the prior quarter.
- Over the last five years, Interest Expenses for NAGE reached as high as $5.3 million in Q2 2022 and fell as low as -$636000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $2.2 million across 5 years, with a median of $657000.0 in 2025.
- On a YoY basis, Interest Expenses climbed as much as 1482.11% in 2025 and fell as far as 362.81% in 2025.
- Year by year, Interest Expenses stood at $135000.0 in 2022, then declined by 24.44% to $102000.0 in 2023, then jumped by 137.25% to $242000.0 in 2024, then plunged by 362.81% to -$636000.0 in 2025, then jumped by 166.19% to $421000.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $421000.0 in Q1 2026, -$636000.0 in Q4 2025, and $657000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 421,000.00 |
| Mar 31, 2026 | 421,000.00 |
| Dec 31, 2025 | -636,000.00 |
| Dec 31, 2025 | -636,000.00 |
| Sep 30, 2025 | 657,000.00 |
| Sep 30, 2025 | 657,000.00 |
| Jun 30, 2025 | 3.89 Mn |
| Jun 30, 2025 | 3.89 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 242,000.00 |
| Dec 31, 2024 | 242,000.00 |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |